Will Curaleaf Holdings Inc (CURLF) Outperform the Healthcare Sector?

Monday, August 3, 2020 2:52 PM | InvestorsObserver Analysts

The 84 rating InvestorsObserver gives to Curaleaf Holdings Inc (CURLF) stock puts it near the top of the Healthcare sector.

In addition to scoring higher than 71 percent of stocks in the Healthcare sector, CURLF’s 84 overall rating means the stock scores better than 84 of all stocks.

Overall Score - 84
CURLF has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on CURLF!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 84 would rank higher than 84 percent of all stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease.

These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Curaleaf Holdings Inc Stock Today?

Curaleaf Holdings Inc (CURLF) stock is trading at $8.99 as of 2:36 PM on Monday, Aug 3, an increase of $0.55, or 6.52% from the previous closing price of $8.44. The stock has traded between $8.48 and $9.25 so far today. Volume today is 642,087 compared to average volume of 556,437.

To see InvestorsObserver's Sentiment Score for CURLF click here.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Nikkei 225 Down 1.5% on Wall Street Cues, US Presidential Debates

Sector Update: Afternoon Recovery for Health Care Stocks

Sector Update: Health Care

Where Will Celldex Therapeutics, Inc. (CLDX) Stock Go Next After It Is Up 23.13% in a Week?

Related Companies